Fig. 1.
Structure of rolapitant. Rolapitant contains a spirolactam ring structure with three chiral centers and has a molecular weight of 500.2 g/mol. The arrow indicates the site of hydroxylation by CYP3A4 to form the major metabolite, M19.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.